Milestone for gene-edited therapy for sickle cell disease
Vertex Pharmaceuticals (Europe) and CRISPR Therapeutics have announced that the European Medicines Agency (EMA) has…
Vertex Pharmaceuticals (Europe) and CRISPR Therapeutics have announced that the European Medicines Agency (EMA) has…
Companies in the cell and gene therapy space are struggling to raise investments amid adverse…
Here’s a list of the public European biotech companies that are worth more than a…
Current treatments for cystic fibrosis are not suitable for all patients and have a limited…
CRISPR-Cas9 has taken the world by storm with the promise of making gene editing much…
Confidence in gene-edited T cell therapies from donor cells has faltered as Allogene Therapeutics paused…
Last month, the US firm bluebird bio abandoned the sale of its gene therapy Zynteglo…
Tony Ho, Head of Research and Development at CRISPR Therapeutics, offers his insights into the…
As we enter 2021, the biotech industry is already bustling with activity. Here’s a list…
Under the heavy shadow of the Covid-19 pandemic, last week’s annual conference of the American…
CRISPR Therapeutics and its US partner Vertex Pharmaceuticals have released the first clinical results for…
New approaches to tame the immune system in the fight against cancer are getting us…